Human Liver Models Market by Type and Geography - Forecast and Analysis 2022-2026

The human liver models market share is expected to increase by USD 1.91 billion from 2021 to 2026, at a CAGR of 12.94%.

This human liver models market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers human liver models market segmentation by type (liver organoids, liver-on-a-chip, 2D models, and 3D bioprinting) and geography (North America, Europe, APAC, Middle East and Africa, and South America). The human liver models market report also offers information on several market vendors, including BioIVT LLC, CELLINK AB, CN Bio Innovations Ltd., Corning Inc., Cyfuse Biomedical K.K., Emulate Inc., H. L. Scientific, Hangzhou Jienuofei Biotechnology Co. Ltd., InSphero AG, Kirkstall Ltd., LifeSpan BioSciences Inc., MIMETAS BV, N. C. KANSIL and SONS, Organovo Holdings Inc., Pandorum Technologies Pvt. Ltd., STEMCELL Technologies Inc., Thermo Fisher Scientific Inc., and Western Surgical among others.

What will the Human Liver Models Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Human Liver Models Market Size for the Forecast Period and Other Important Statistics

 

Human Liver Models Market: Key Drivers, Trends, and Challenges

The increasing prevalence of liver diseases is notably driving the human liver models market growth, although factors such as lack of adequate healthcare infrastructure in developing nations may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the human liver models industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Human Liver Models Market Driver

One of the key factors driving growth in the human liver models market is the increasing prevalence of liver diseases. Liver cancer is among the leading causes of cancer-related deaths globally. The increase in the incidence of risk factors like hepatitis B and C and underlying cirrhosis will lead to the rise in the risk of liver cancer depending on the etiology. The increase in the incidence of lifestyle diseases like fatty liver is a major risk factor for liver cancer. Long-term alcohol consumption is also the primary reason for the increase in the incidence of liver cancer. Furthermore, the increase in the incidence of new risk factors such as diabetes, obesity, and related non-alcoholic fatty liver disease may also be associated with the increase in the incidence of liver diseases. The current disease management for liver diseases is the same for all patients with different etiologies. Advances in disease management and R and D for the causative factors may reduce the incidence of liver cancer, which will increase the application of human liver models.

Key Human Liver Models Market Trend

The technological advancements in the human organ model is another factor supporting the human liver models market share growth. 3D tissue and organ models can better represent the spatial and biological complexity of living tissues, enable a more accurate assessment of therapeutic efficacy and safety, and decrease the cost of drug discovery. Thus, it will provide an effective alternative to traditional 2D cell culture and animal models. Therefore, human cells-based 3D tissue and organ models have recently emerged as robust platforms, which can facilitate tissue regeneration, organ transplantation and repair, drug discovery, toxicological screening, as well as in vitro disease modeling in both basic and clinical research. Various powerful techniques have been developed for 3D tissue and organ models, including organoid culture, 3D bioprinting, microfluidics, organs on chips, functional biomaterials for tissue engineering, and so forth.  Thus, the growing technological advancements in the human organ model will positively impact the market in focus.

Key Human Liver Models Market Challenge

The lack of adequate healthcare infrastructure in developing nations will be a major challenge for the human liver models market during the forecast period. In underdeveloped and developing economies such as India, Argentina, and African countries, there is a lack of adequate healthcare infrastructure due to limited healthcare expenditure. This is one of the major factors restraining the adoption of treatment in countries such as India, Brazil, and South Africa. Only a limited number of healthcare institutions in underdeveloped and developing countries can use advanced radiotherapy systems for cancer treatment. This limits the number of radiotherapy and chemotherapy procedures despite their high demand. Thus, the lack of infrastructure and inadequate expenditure in the healthcare sector are expected to hinder the adoption of human liver models, which, in turn, will negatively impact the growth of the market.

This human liver models market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global human liver models market as a part of the global healthcare equipment market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the human liver models market during the forecast period.

Who are the Major Human Liver Models Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

 

• BioIVT LLC
• CELLINK AB
• CN Bio Innovations Ltd.
• Corning Inc.
• Cyfuse Biomedical K.K.
• Emulate Inc.
• H. L. Scientific
• Hangzhou Jienuofei Biotechnology Co. Ltd.
• InSphero AG
• Kirkstall Ltd.
• LifeSpan BioSciences Inc.
• MIMETAS BV
• N. C. KANSIL and SONS
• Organovo Holdings Inc.
• Pandorum Technologies Pvt. Ltd.
• STEMCELL Technologies Inc.
• Thermo Fisher Scientific Inc.
• Western Surgical

 

This statistical study of the human liver models market encompasses successful business strategies deployed by the key vendors. The human liver models market is fragmented and the vendors are deploying growth strategies such as acquiring and forming mergers with other vendors to increase their market share to compete in the market.

Product Insights and News

• BioIVT LLC - In January, the company launched GMP grade human AB serum to facilitate the development and manufacturing of cell and gene therapies.
• CELLINK AB - The company offers human liver model namely HUREL Micro Livers.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The human liver models market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Human Liver Models Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the human liver models market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for Human Liver Models Market?

For more insights on the market share of various regions Request for a FREE sample now!

35% of the market's growth will originate from North America during the forecast period. The US is the key market for human liver models in North America. Market growth in this region will be slower than the growth of the market in other regions.

Considerable investments in the pharmaceutical industry, specifically the oncology sector, and the presence of pharmaceutical giants in the region will facilitate the human liver models market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

In 2020, the outbreak of COVID-19 negatively impacted the economies of various countries in the region. Governments of various countries such as the US, Canada, and others in the region imposed a nationwide lockdown, which limited the movement of people. In the first half of 2021, with the gradual decrease in the number of COVID-19 cases, lockdowns were lifted, leading to the reopening of healthcare facilities and clinics. This has led to the resumption of regular operations and checkups for cancer patients. Such factors are expected to positively impact the demand for liver cancer drugs, which, in turn, will drive the market during the forecast period.

What are the Revenue-generating Type Segments in the Human Liver Models Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The human liver models market share growth by the liver organoids segment will be significant during the forecast period. The increasing need for diagnosis of liver disease owing to the need for R and D and drug development is expected to drive the growth of the segment, which, in turn, will drive the market during the forecast period. In recent years, liver diseases have been one of the most common pathologies in the digestive system and have a high incidence. Also, the incidence of liver diseases has gradually increased owing to drinking, obesity, viral which include hepatitis B virus (HBV) or hepatitis C virus (HCV) infection, and other reasons. 

This report provides an accurate prediction of the contribution of all the segments to the growth of the human liver models market size and actionable market insights on post COVID-19 impact on each segment.

You may be interested in:

Human Organoids market - The market share is expected to increase to USD 1.18 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 16.9%.

Human Liver Models Market Scope
Report Coverage	Details
Page number	120
Base year	2021
Forecast period	2022-2026
Growth momentum & CAGR	Decelerate at a CAGR of 12.94%
Market growth 2022-2026	$ 1.91 billion
Market structure	Fragmented
YoY growth (%)	16.76
Regional analysis	North America, Europe, APAC, Middle East and Africa, and South America
Performing market contribution	North America at 35%
Key consumer countries	US, China, Japan, Germany, and UK
Competitive landscape	Leading companies, Competitive strategies, Consumer engagement scope
Key companies profiled	BioIVT LLC, CELLINK AB, CN Bio Innovations Ltd., Corning Inc., Cyfuse Biomedical K.K., Emulate Inc., H. L. Scientific, Hangzhou Jienuofei Biotechnology Co. Ltd., InSphero AG, Kirkstall Ltd., LifeSpan BioSciences Inc., MIMETAS BV, N. C. KANSIL and SONS, Organovo Holdings Inc., Pandorum Technologies Pvt. Ltd., STEMCELL Technologies Inc., Thermo Fisher Scientific Inc., and Western Surgical
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Human Liver Models Market Report?

• CAGR of the market during the forecast period 2022-2026
• Detailed information on factors that will drive human liver models market growth during the next five years
• Precise estimation of the human liver models market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the human liver models industry across North America, Europe, APAC, Middle East and Africa, and South America
• A thorough analysis of the market's competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of human liver models market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch